1. Home
  2. COEP vs SURG Comparison

COEP vs SURG Comparison

Compare COEP & SURG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • COEP
  • SURG
  • Stock Information
  • Founded
  • COEP 2017
  • SURG 2006
  • Country
  • COEP United States
  • SURG United States
  • Employees
  • COEP N/A
  • SURG N/A
  • Industry
  • COEP Biotechnology: Biological Products (No Diagnostic Substances)
  • SURG Advertising
  • Sector
  • COEP Health Care
  • SURG Consumer Discretionary
  • Exchange
  • COEP Nasdaq
  • SURG Nasdaq
  • Market Cap
  • COEP 32.4M
  • SURG 31.3M
  • IPO Year
  • COEP N/A
  • SURG N/A
  • Fundamental
  • Price
  • COEP $11.54
  • SURG $1.43
  • Analyst Decision
  • COEP
  • SURG Buy
  • Analyst Count
  • COEP 0
  • SURG 2
  • Target Price
  • COEP N/A
  • SURG $8.50
  • AVG Volume (30 Days)
  • COEP 135.7K
  • SURG 117.7K
  • Earning Date
  • COEP 03-25-2025
  • SURG 03-11-2025
  • Dividend Yield
  • COEP N/A
  • SURG N/A
  • EPS Growth
  • COEP N/A
  • SURG N/A
  • EPS
  • COEP N/A
  • SURG N/A
  • Revenue
  • COEP N/A
  • SURG $83,602,653.00
  • Revenue This Year
  • COEP N/A
  • SURG N/A
  • Revenue Next Year
  • COEP N/A
  • SURG $59.69
  • P/E Ratio
  • COEP N/A
  • SURG N/A
  • Revenue Growth
  • COEP N/A
  • SURG N/A
  • 52 Week Low
  • COEP $2.31
  • SURG $1.33
  • 52 Week High
  • COEP $13.70
  • SURG $9.23
  • Technical
  • Relative Strength Index (RSI)
  • COEP 59.40
  • SURG 31.02
  • Support Level
  • COEP $8.65
  • SURG $1.33
  • Resistance Level
  • COEP $13.70
  • SURG $1.45
  • Average True Range (ATR)
  • COEP 2.11
  • SURG 0.08
  • MACD
  • COEP -0.24
  • SURG -0.01
  • Stochastic Oscillator
  • COEP 61.22
  • SURG 16.67

About COEP Coeptis Therapeutics Holdings Inc.

Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.

About SURG SurgePays Inc.

Surgepays Inc is a fintech company focused on the underbanked community. It provides services to financial technology, telecommunications, and digital media companies. Its operating segment includes Mobile Virtual Network Operators that provide mobile broadband (internet connectivity), voice and SMS text messaging to both subsidized and direct retail prepaid customers through SurgePhone Wireless, LLC and Torch Wireless, LLC; Comprehensive Platform Services provide financial technology and a wireless top-up platform to independently owned convenience stores throughout the country; Lead Generation is a generation and case management solutions company serving law firms in the mass tort industry; and Others. It generates the revenue from Mobile Virtual Network Operator segment.

Share on Social Networks: